Cita APA (7a ed.)

Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report: Mifepristone and misoprostol (Mifegymiso). Canadian Agency for Drugs and Technologies in Health.

Cita Chicago Style (17a ed.)

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Mifepristone and Misoprostol (Mifegymiso). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.

Cita MLA (9a ed.)

Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Mifepristone and Misoprostol (Mifegymiso). Canadian Agency for Drugs and Technologies in Health, 2017.